
IDEXX Laboratories Inc
NASDAQ:IDXX

Intrinsic Value
The intrinsic value of one
IDXX
stock under the Base Case scenario is
271.57
USD.
Compared to the current market price of 417.71 USD,
IDEXX Laboratories Inc
is
Overvalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
IDEXX Laboratories Inc
Fundamental Analysis

IDEXX’s significant exposure to the companion animal diagnostics market leaves it vulnerable to heightened competition from emerging, lower-cost testing solutions, potentially eroding the firm’s premium pricing power and margins.
IDEXX’s strong brand reputation and broad portfolio of proprietary diagnostic instruments and assays provide significant pricing power and high switching costs, allowing it to maintain above-average margins.

Revenue & Expenses Breakdown
IDEXX Laboratories Inc
Balance Sheet Decomposition
IDEXX Laboratories Inc
Current Assets | 1.4B |
Cash & Short-Term Investments | 288.3m |
Receivables | 561.3m |
Other Current Assets | 550.3m |
Non-Current Assets | 1.9B |
Long-Term Investments | 57.7m |
PP&E | 829.3m |
Intangibles | 516.8m |
Other Non-Current Assets | 489.8m |
Free Cash Flow Analysis
IDEXX Laboratories Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
IDEXX Laboratories Inc
Revenue
|
3.9B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
2.4B
USD
|
Operating Expenses
|
-1.2B
USD
|
Operating Income
|
1.1B
USD
|
Other Expenses
|
-245m
USD
|
Net Income
|
887.9m
USD
|
IDXX Profitability Score
Profitability Due Diligence
IDEXX Laboratories Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Score
IDEXX Laboratories Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
IDXX Solvency Score
Solvency Due Diligence
IDEXX Laboratories Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Score
IDEXX Laboratories Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IDXX Price Targets Summary
IDEXX Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
IDXX
is 522.8 USD
with a low forecast of 410.16 USD and a high forecast of 594.3 USD.
Dividends
Current shareholder yield for IDXX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IDXX
stock under the Base Case scenario is
271.57
USD.
Compared to the current market price of 417.71 USD,
IDEXX Laboratories Inc
is
Overvalued by 35%.